82 FR 19058 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Establishment Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution and Blood Establishment Registration and Product Listing

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 82, Issue 78 (April 25, 2017)

The Food and Drug Administration (FDA) is announcing that two collections of information: ``Establishment Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution'' and ``Blood Establishment Registration and Product Listing'' have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

[Federal Register Volume 82, Number 78 (Tuesday, April 25, 2017)]
[Notices]
[Pages 19058-19059]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-08305]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2005-N-0464 (Formerly Docket No. 2005N-0403)]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Establishment Registration of 
Producers of Drugs and Listing of Drugs in Commercial Distribution and 
Blood Establishment Registration and Product Listing

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that two 
collections of information: ``Establishment Registration of Producers 
of Drugs and Listing of Drugs in Commercial Distribution'' and ``Blood 
Establishment Registration and Product Listing'' have been approved by 
the Office of Management and Budget (OMB) under the Paperwork Reduction 
Act of 1995.

FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of 
Operations, Food and Drug Administration, Three White Flint North 10A-
12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-3794.

SUPPLEMENTARY INFORMATION: On December 16, 2016, the Agency submitted 
proposed collections of information entitled ``Establishment 
Registration of Producers of Drugs and Listing of Drugs in Commercial 
Distribution'' and ``Blood Establishment Registration and Product 
Listing'' to

[[Page 19059]]

OMB for review and clearance under 44 U.S.C. 3507. An Agency may not 
conduct or sponsor, and a person is not required to respond to, a 
collection of information unless it displays a currently valid OMB 
control number. OMB has now approved the information collection and has 
assigned OMB control numbers 0910-0045 and 0910-0052, respectively. The 
information collection 0910-0045 expires on December 31, 2018, and the 
information collection 0910-0052 expires May 31, 2018. Copies of the 
supporting statements for the information collections are available on 
the Internet at http://www.reginfo.gov/public/do/PRAMain.

    Dated: April 18, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-08305 Filed 4-24-17; 8:45 am]
 BILLING CODE 4164-01-P